Medical Supplies News

LOUISVILLE, Ky.--(BUSINESS WIRE)--A new study published in the current issue of the Journal of Managed Care & Specialty Pharmacy (JMCP)—conducted by a Humana Healthcare Research team and Dr. Joseph S. Ross of the Yale School of Medicine—reveals a notable increase in the use of continuous glucose monitors (CGMs) among Medicare Advantage members with type 2 diabetes from 2021 to 2023. The study also compared the demographic and clinical characteristics of members with type 2 diabetes who used...

DALLAS--(BUSINESS WIRE)--o9, a leading enterprise AI software platform provider for transforming planning and decision-making, today announced that Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, is now live globally with Demand Planning and Supply Planning on the o9 platform. This deployment supports Teleflex’s multi-year effort to enhance its end-to-end integrated business planning and supply chain management capabilities. With Demand Planning and Supply...

ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, has reached an agreement with BeauBrain Healthcare that brings its breakthrough diagnostic testing for Alzheimer’s disease to South Korea. The partnership means health care professionals in South Korea now have access to C2N’s PrecivityAD2™ test, which is an innovative blood test intended for use in patients 50 and older with signs or symptoms of mild cog...

NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthTrust Performance Group™ (HealthTrust), a leading healthcare performance improvement organization, shaped the national conversation at the 2026 Federation of American Hospitals (FAH) Conference and Business Exposition, held February 23-25 in Las Vegas, Nevada. The annual event brought together more than 1,300 healthcare supply chain leaders representing hospital management companies, health systems, integrated delivery networks (IDNs), group purchasing o...

PARMA, Italy & HOLMES CHAPEL, England--(BUSINESS WIRE)--Chiesi Group ("Chiesi"), the international research focused biopharmaceutical company and a certified B Corp, and Bespak, the specialist inhalation CDMO focused on pulmonary and nasal drug delivery, today announced an expansion of their long-standing partnership, increasing pressurized metered dose inhaler (pMDI) manufacturing capacity at Bespak’s Holmes Chapel site to support the next phase of Chiesi’s Carbon Minimal Inhaler (CMI) program...

ACTON, Mass.--(BUSINESS WIRE)--Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at ATTD...

CHICAGO--(BUSINESS WIRE)--Emalex Biosciences today announced that the first patient was dosed in its Expanded Access Program for ecopipam, an investigational first-in-class D1 receptor antagonist in development for the treatment of Tourette syndrome. The Expanded Access Program will enroll approximately 200 patients at sites across the United States. A current list of participating sites for the trial, NCT07093541, is available on ClinicalTrials.gov. The program allows physicians to request eco...

FALLS CHURCH, Va.--(BUSINESS WIRE)--RDX-002 resulted in 57% less weight regain after GLP-1 therapy, showing promise as a durable and well-tolerated weight management option....

LEXINGTON, Mass.--(BUSINESS WIRE)--FUJIFILM Healthcare Americas Corporation, a leading provider of enterprise imaging and informatics solutions, will showcase how its latest AI-powered enterprise imaging solutions are enabling healthcare organizations to enhance workflows for faster patient throughput, reduce administrative burden, and support more personalized care at the Healthcare Information and Management Systems Society (HIMSS) conference held March 9 – 12 in Las Vegas. “AI delivers excep...

NASHVILLE, Tenn. & MENLO PARK, Calif.--(BUSINESS WIRE)--Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing generative vision-language models (VLMs) for radiology, has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for Cognita Chest X-Ray (CXR)™1 across multiple critical indications. Cognita CXR is an industry-first generative vision-language model designed to assi...